DanCann Pharma was founded in 2018 and is a Danish pharmaceutical company. DanCann Pharma focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in a broad range of disease areas. The company makes prescription (Rx-pharmaceuticals) and over-the-counter (OTC) pharmaceuticals mainly focused on pain patients with alternative needs and management to handle their illness, covered by the Danish Pilot Programme for medical cannabis.

Quotes for DanCann Pharma A/S

Created with Highstock 6.0.7CloseTraded Volume12. maj19. maj26. maj9. jun16. jun23. jun30. jun7. jul14. jul21. jul28. jul4. aug0.7511.251.51.750120T240T360T480T

Right Now

+/-
0.085
%
9,34%
Latest
0.995
High
0.995
Low
0.86
Volume
42 501
Turnover (DKK)
38 539
Market Value (MDKK)
4,0
Time (Latest trade)
2025-08-06 15:41

Board

CEO

  • Jeppe Krog Rasmussen

Chairperson of the Board

  • Carsten Trads

Board

  • Jeppe Krog Rasmussen
  • Christian Carlsen
  • Jes Lunde

Largest Owners

Name Capital % Votes % Date
JEQ Capital AB 10,42 10,42 2024-11-25
Robert Burén 4,20 4,20 2024-11-25
Niklas Estensson 4,20 4,20 2024-11-25
Alexander Schoeneck 3,83 3,83 2024-11-25
Erik Lundin 3,15 3,15 2024-11-25
Love Carlsson 2,52 2,52 2024-11-25
Johan Alexander Kangas 2,52 2,52 2024-11-25
Nils Berg 2,52 2,52 2024-11-25
Östen Carlssson 2,10 2,10 2024-11-25
Jonas Hagberg med bolag 2,10 2,10 2024-11-25
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Insider trading

NameTransaction DateTypeInstrumentAmountPriceValueCurrency
Morten Martinsen2021-12-30Sell TransactionDanCann Pharma- 25 6908,13−208 789,5SEK
John Frellsen2021-07-26Buy TransactionDanCann Pharma 25 0005,14128 468,1SEK
Jeppe Krog Rasmussen2021-07-26Buy TransactionDanCann Pharma 267 0235,141 372 157,7SEK
Jeppe Krog Rasmussen2021-03-30Buy TransactionDanCann Pharma 50 0004,48223 908,7SEK
Jeppe Krog Rasmussen2021-03-19Buy TransactionDanCann Pharma 50 0004,45222 260,1SEK
Jeppe Krog Rasmussen2021-03-01Buy TransactionDanCann Pharma 40 0004,3172 004,1SEK
Jeppe Krog Rasmussen2021-02-26Buy TransactionDanCann Pharma 60 0004,39263 419,8SEK
*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

2025-03-312024-12-312024-12-312024-09-302024-06-302024-03-312023-12-31
Number of months that the report spans Q1 3 Months2024Q4 3 MonthsQ3 3 MonthsQ2 3 MonthsQ1 3 Months2023
Total revenue MDKK0.247.761.341.863.860.706.07
Earnings before interest and tax MDKK-2.83-6.69-2.22-1.42-0.40-2.65-14.12
Profit before tax MDKK-2.93-7.93-1.89-1.75-0.95-3.34-15.33
Net profit MDKK-2.93-7.93-1.84-2.86-0.63-2.60-12.34
Earnings per share DKK-0.00-0.000.00-0.00-0.00-0.00-0.00
Dividend per share DKK0.000.00
Equity MDKK12.2513.5713.5713.316.357.6260.48
Fixed assets MDKK3.013.193.193.373.573.948.62
Intangible assets MDKK8.886.996.998.999.308.3650.94
Current assets MDKK2.424.564.563.047.342.564.73
Total asset MDKK14.6215.0615.0615.7220.5315.1764.61
Long term liabilities MDKK0.000.000.000.000.000.000.00
Current liabilities MDKK2.091.491.492.4114.187.554.14
Number of shares DKK3991.053991.053991.051541.101206.10166.63141.63
*Compiled data from Millistream